Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Inflammatory Bowel Diseases
Clinical trial register · Canada

Inflammatory Bowel Diseases Trials in Canada, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6567 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:20 UTC
6567
Studies in scope
all four open statuses
3491
Recruiting now
open to new participants
883
Lead sponsors
across recruiting studies
Top sites
London 6 Ottawa 5 Toronto 5 Halifax 4 Montreal 4

Inflammatory Bowel Diseases trials in Canada

18 of 6567 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Recruiting
Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population
NCT07401680Ulcerative Colitis, Inflammatory Bowel Diseases, Clostridioides Difficile Infection
University of Alberta
Phase 1
85
Calgary, Edmonton
2026-03-01
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
Spyre Therapeutics, Inc.
Phase 2
645
London, Toronto, Chicoutimi, Montreal, Greater Sudbury
2025-05-27
Recruiting
Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease
NCT06548399Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis
McMaster University
Observational
15
Hamilton
2024-12-01
Active, closed
Children's Hospital of Eastern Ontario
Not applicable
45
Ottawa
2024-12-01
Recruiting
AIRE-2 Device for Study of Breath Analysis in IBD
NCT06541938Inflammatory Bowel Diseases
McMaster University
Not applicable
60
Hamilton
2024-08-28
Recruiting
Predicting IBD Treatment Outcomes With Gut Microbiome Analysis
NCT06453720Inflammatory Bowel Diseases, Crohn Disease
University of British Columbia
Observational
100
Vancouver
2024-08-01
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Alberta, Chicoutimi, Halifax, Lethbridge, London, Montreal, Québec, Scarborough
2024-07-18
Recruiting
Personalized B-fructan Diet in Inflammatory Bowel Disease Patients
NCT05615779Inflammatory Bowel Diseases, Ulcerative Colitis
University of Manitoba
Not applicable
600
Edmonton, Winnipeg
2023-08-01
Recruiting
IBD Strong Peer2Peer for Self-Management of Psychological Distress
NCT05722236Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn Disease
Jennifer Jones
Not applicable
120
Halifax
2023-06-01
Recruiting
Genome Analysis Across Populations in Inflammatory Bowel Disease
NCT06042387Ulcerative Colitis, Healthy, Crohn Disease, Inflammatory Bowel Diseases
Mount Sinai Hospital, Canada
Observational
150
Toronto
2022-05-01
Active, closed
Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care
NCT05221281Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis, Adolescent Development
The Hospital for Sick Children
Not applicable
90
Vancouver, Ottawa, Toronto
2022-02-25
Active, closed
Beth Israel Deaconess Medical Center
Phase 4
124
London, Montreal
2021-11-01
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
Eli Lilly and Company
Phase 3
150
London, Toronto
2021-05-26
Active, closed
OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND Trial
NCT04520594Crohn Disease, Ulcerative Colitis, Inflammatory Bowel Diseases
Children's Hospital of Eastern Ontario
Not applicable
100
Ottawa
2021-03-03
Active, closed
Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)
NCT04522271Crohn Disease, Ulcerative Colitis, Inflammatory Bowel Diseases
Children's Hospital of Eastern Ontario
Not applicable
80
Ottawa
2020-08-25
Active, closed
TDM Guided Early Optimization of ADAL in Crohn's Disease
NCT03261102Crohn Disease, Drug Monitoring, Inflammatory Bowel Diseases
waqqas.afif
Not applicable
200
Calgary, Vancouver, London, Ottawa, Montreal, Sherbrooke
2017-01-17
Recruiting
The Canadian Children Inflammatory Bowel Disease Network (CIDsCaNN)
NCT02308917Inflammatory Bowel Diseases, Crohn's, Ulcerative Colitis
The Hospital for Sick Children
Observational
2,400
Calgary, Edmonton, Vancouver, Winnipeg, St. John's, Halifax, Hamilton, London
2013-09
Active, closed
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
NCT00606346Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis, Inflammatory Bowel Diseases
Janssen Biotech, Inc.
Observational
4,970
Edmonton, Halifax, Burlington, Toronto
2007-05-31
Rows per page Showing 1–18 of 18
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-canada/condition/inflammatory-bowel-diseases

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,567 studies in total at the last sync on 13 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 18 of those studies listing the condition Inflammatory Bowel Diseases.

How many Inflammatory Bowel Diseases trials are recruiting in Canada?

11 of the 18 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Inflammatory Bowel Diseases), 18 studies
PhaseStudiesRecruitingShare
Not applicable8344.4%
Observational5427.8%
Phase 22211.1%
Phase 1115.6%
Phase 3115.6%
Phase 4105.6%

Most active sponsors

Lead sponsors with the most studies (Inflammatory Bowel Diseases)
Lead sponsorStudiesRecruiting
Children's Hospital of Eastern Ontario30
McMaster University22
The Hospital for Sick Children21
Beth Israel Deaconess Medical Center10
Eli Lilly and Company11
Janssen Biotech, Inc.10
Jennifer Jones11
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)11
Mount Sinai Hospital, Canada11
Spyre Therapeutics, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.